Skip to main content
SpringerLink
Log in

Cyclophosphamide/fludarabine/rituximab

Reactivation of hepatitis B virus leading to fatal acute liver failure: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Wasmuth J-C, Fischer H-P, Sauerbruch T, Dumoulin FL.Fatal acute liver failure due to reactivation of hepatitis B following treatment with fludarabine/cyclophosphamide/rituximab for low grade non-Hodgkin's lymphoma. European Journal of Medical Research 13: 483-486, No. 10, 27 Oct 2008 - Germany

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cyclophosphamide/fludarabine/rituximab. React. Wkly. 1232, 13 (2008). https://doi.org/10.2165/00128415-200812320-00037

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200812320-00037

Keywords

Search

Navigation